tiprankstipranks
Trending News
More News >

Geraldine Henwood Insider Profile

4 Followers
Geraldine Henwood, President & CEO, Director at Recro Pharma, holds 211.19K shares in Recro Pharma (Ticker: REPH), holds 387.89K shares in Baudax Bio (Ticker: BXRX), holds 0.00 shares in Tetraphase (Ticker: TTPH).
tipranks
Geraldine Henwood

Geraldine Henwood
Recro Pharma (REPH)
President & CEO, Director

Ranked #52,581 out of 78,624 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-19.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$974K
54.20%
45.80%
0.00%
A breakdown of Geraldine Henwood's holdings

Insider Roles

Recro Pharma
(REPH)
President & CEO, Director
Baudax Bio
(BXRX)
President & CEO, Director
Alkermes
(ALKS)
Director
Roles that Geraldine Henwood holds in companies

Most Profitable Insider Trade

Stock:
Alkermes
(ALKS)
Rating:Informative Sell
Date:Feb 23, 2012 - Feb 23, 2013
Return:-18.30%
The most profitable trade made by Geraldine Henwood

Geraldine Henwood's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Recro Pharma
Apr 20, 2020
President & CEO, Director
Uninformative Sell
657.60K
$527.99K
Baudax Bio
Jan 29, 2020
President & CEO, Director
Uninformative Sell
42.98K
$446.07K
TTPH
Tetraphase
$0.00
AUXL
Auxilium
Alkermes
Jan 16, 2014
Director
Uninformative Sell
1.90M
$0.00
MAPP
Map Pharmaceuticals
List of latest transactions for each holding click on a transaction to see Geraldine Henwood's performance on stock

Geraldine Henwood insider profile FAQ

What is the percentage of profitable transactions made by Geraldine Henwood?
The percentage of profitable transactions made by Geraldine Henwood is 0%.
    What is the average return per transaction made by Geraldine Henwood?
    The average return per transaction made by Geraldine Henwood is -19.60%.
      What stocks does Geraldine Henwood hold?
      Geraldine Henwood holds: REPH, BXRX, TTPH, AUXL, ALKS, MAPP stocks.
        What was Geraldine Henwood’s latest transaction?
        Geraldine Henwood latest transaction was an Uninformative Sell of $657.60K.
          What was Geraldine Henwood's most profitable transaction?
          Geraldine Henwood’s most profitable transaction was an Informative Sell of ALKS stock on February 23, 2012. The return on the trade was -18.30%.
            What is Geraldine Henwood's role in Recro Pharma?
            Geraldine Henwood's role in Recro Pharma is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.